ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Singular Genomics Systems Inc

Singular Genomics Systems Inc (OMIC)

8.39
0.01
( 0.12% )
Updated: 10:41:43

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
8.39
Bid
8.40
Ask
8.95
Volume
206
8.39 Day's Range 8.39
7.50 52 Week Range 31.50
Market Cap
Previous Close
8.38
Open
8.39
Last Trade
1
@
8.4001
Last Trade Time
11:57:29
Financial Volume
-
VWAP
-
Average Volume (3m)
120,220
Shares Outstanding
2,469,766
Dividend Yield
-
PE Ratio
-0.22
Earnings Per Share (EPS)
-38.39
Revenue
2.91M
Net Profit
-94.82M

About Singular Genomics Systems Inc

Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. The product development pipeline comprises two initial integrated solutions, each designed to ... Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. The G4 Integrated Solution is designed to target the NGS market. The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets. Both integrated solutions are used in many different and diverse market segments, including basic biology, oncology, immunology, neurology, genetic diseases, infectious diseases, the human microbiome and many others. Show more

Sector
Lab Analytical Instruments
Industry
Lab Analytical Instruments
Headquarters
Dover, Delaware, USA
Founded
1970
Singular Genomics Systems Inc is listed in the Lab Analytical Instruments sector of the NASDAQ with ticker OMIC. The last closing price for Singular Genomics Systems was $8.38. Over the last year, Singular Genomics Systems shares have traded in a share price range of $ 7.50 to $ 31.50.

Singular Genomics Systems currently has 2,469,766 shares outstanding. The market capitalization of Singular Genomics Systems is $20.70 million. Singular Genomics Systems has a price to earnings ratio (PE ratio) of -0.22.

OMIC Latest News

Singular Genomics Regains Compliance with Nasdaq Minimum Bid Price Requirement

SAN DIEGO, July 15, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to...

Singular Genomics Announces 1-for-30 Reverse Stock Split

SAN DIEGO, June 21, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.729.387222946547.679.9267.5153158.33196628CS
4-1.99-19.171483622410.3812.377.51075229.1473198CS
12-3.61-30.08333333331215.67.512022010.95000539CS
26-4.81-36.439393939413.219.87.511667913.11756776CS
52-18.91-69.267399267427.331.57.526634414.27609675CS
156-618.31-98.6612414233626.7665.47.5274255120.09229955CS
260-861.61-99.03563218398701001.17.5277042155.99370577CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SILOSilo Pharma Inc
$ 2.1467
(100.63%)
115.6M
TKLFYoshitsu Company Ltd
$ 0.5949
(94.25%)
251M
NAASNaaS Technology Inc
$ 4.075
(45.54%)
11.91M
PACBPacific Biosciences of California Inc
$ 2.105
(29.94%)
12.74M
VRPXVirpax Pharmaceuticals Inc
$ 1.37
(28.04%)
10.35M
CYNCYNGN Inc
$ 6.78
(-26.14%)
620.24k
AMIXAutonomix Medical Inc
$ 1.045
(-24.28%)
4.74M
ASLNASLAN Pharmaceuticals Ltd
$ 1.13
(-18.12%)
433.19k
LGHLWLion Group Holding Ltd
$ 0.0073
(-17.05%)
45.45k
BCDABioCardia Inc
$ 3.00
(-15.25%)
109.54k
TKLFYoshitsu Company Ltd
$ 0.5949
(94.25%)
251M
SILOSilo Pharma Inc
$ 2.1467
(100.63%)
115.6M
NVDANVIDIA Corporation
$ 126.79
(-1.28%)
104.14M
CDTConduit Pharmaceuticals Inc
$ 0.2893
(20.54%)
88M
MAXNMaxeon Solar Technologies Ltd
$ 0.2446
(7.75%)
71.08M

OMIC Discussion

View Posts
Monksdream Monksdream 3 weeks ago
OMIC new 52 week low
πŸ‘οΈ0
Monksdream Monksdream 4 months ago
OMIC 10Q due 3/18
πŸ‘οΈ0
Michael TRed Michael TRed 8 months ago
Easy $ tomorrow...
πŸ‘οΈ0
DarkPool DarkPool 8 months ago
Short boys. Ihub top contrerian has spoken.
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 8 months ago
OMIC NEXT BIO POPADOPPER
πŸ‘οΈ0
Monksdream Monksdream 10 months ago
OMIC new 52 week low
πŸ‘οΈ0
Monksdream Monksdream 10 months ago
OMIC new 52 week low
πŸ‘οΈ0
Monksdream Monksdream 10 months ago
OMIC new 52 week low
πŸ‘οΈ0
Monksdream Monksdream 10 months ago
OMIC new 52 weewk low
πŸ‘οΈ0
Monksdream Monksdream 11 months ago
OMIC new 52 week low
πŸ‘οΈ0
StockLogistics StockLogistics 2 years ago
Fill the gaps at 3.24 and 3.00
πŸ‘οΈ0
StockLogistics StockLogistics 2 years ago
Gaps 3.00, 3.24, 3.64
πŸ‘οΈ0
StockLogistics StockLogistics 2 years ago
Gap at 3.00
πŸ‘οΈ0
StockLogistics StockLogistics 2 years ago
β€œ4:30p ET 5/10/2022 - Benzinga
Singular Genomics Collaborates With NVIDIA To Deliver Market-Leading Next-Generation Sequencing And Analysis Speeds

Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced the company is collaborating with NVIDIA to validate and optimize the performance of the G4 Sequencing Platform with NVIDIA Clara Parabricks for secondary analysis including alignment and variant calling with over 50 tools for germline and somatic workflows.

This collaboration will enable access to Clara Parabricks for researchers and clinicians using Singular's G4 next-generation instrument, enabling users to run accelerated bioinformatics pipelines for key applications, such as whole genome sequencing, exome sequencing, RNA sequencing (RNA-Seq), and targeted gene panels. This solution will be seamlessly available to customers through Amazon Web Services Cloud implementation or on-premises servers that have NVIDIA GPUs.

"We are thrilled to bring NVIDIA's powerful analytical genomics workflows to Singular Genomics customers as a plug-and-play solution," said Jorge Velarde, Senior Vice President of Corporate Development and Strategy at Singular Genomics. "This collaboration further strengthens our industry-leading speed, providing researchers and clinicians with an opportunity to achieve significantly faster time to results. We look forward to working with NVIDIA and plan to disclose new data in the coming months that demonstrates the optimized performance through these platforms."

NVIDIA technology is used throughout genomics to accelerate traditional and deep learning analytics both within and off instrument for primary, secondary and tertiary genomic analysis. The G4 Sequencing Platform utilizes the NVIDIA RTX A6000 for AI-enabled basecalling. This announcement extends the collaboration to downstream workflows.

"Time to results is crucial across most NGS applications, and we believe that Clara Parabricks and NVIDIA's best-in-class GPU architecture combined with the speed and flexibility of the G4 Sequencing Platform is a natural fit," said George Vacek, Global Director of Genomics Alliances at NVIDIA. "The solution will be impactful to the genomics community and contribute to the advancement of science and medicine."

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.”
πŸ‘οΈ0
StockLogistics StockLogistics 2 years ago
Today: β€œSingular Genomics' management is scheduled to participate in a fireside chat Tuesday, June 14, 2022, at 4:00 p.m. Pacific Time / 7:00 p.m. Eastern Time. Investors and other interested parties are invited to listen to a live and recorded webcast of the presentation on the News & Events section of the company's investor relations website at https://investor.singulargenomics.com/news-events/event-calendar.”
πŸ‘οΈ0
StockLogistics StockLogistics 2 years ago
Reversal to trend higher around 12:30 today
πŸ‘οΈ0
StockLogistics StockLogistics 2 years ago
β€œ11:29a ET 5/11/2022 - Dow Jones
Singular Genomics Systems Is Maintained at Buy by Goldman Sachs”
πŸ‘οΈ0
StockLogistics StockLogistics 2 years ago
β€œCash, cash equivalents and short-term investments, excluding restricted cash, as of March 31, 2022 totaled 316.0 million.”

Outstanding shares: 70 million

316/70 = $4.51 per share with no multiple added and no value placed on the companies products, just based on cash owned by the company this stock is currently undervalued by almost a $1.50 today. Absolutely incredible.
πŸ‘οΈ0
StockLogistics StockLogistics 2 years ago
Follow the cup and handle pattern back to 6.00 a share.
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock